Four-Year Clinical Study Findings Show Significant And Persistent Reduction In Blood Pressure With Rheos(R) System

Medical News Today -- CVRx, Inc. announced the four-year Rheos clinical results from the European study evaluating the Rheos® System at the European Society of Hypertension 20th Meeting. The system is the first device designed to treat hypertension (high blood pressure), a leading cause of heart and kidney disease, stroke and death. This device is a future treatment option for the millions of people who cannot control their blood pressure with medications.